
Background and Objectives
Willbase was established in 2016 to support sales promotion and marketing in the healthcare domain. With the vision of "making healthcare normal and natural," Willbase is working to solve issues in the healthcare industry with its DX tools and consulting capabilities that utilize the latest technology. For the purpose of promoting self-medication, we have developed the "CureBell*1" website to help consumers choose the right OTC drugs and supplements, while for OTC retailers such as drugstores, we have developed the "D We provide "D-Counselor neo*2", a customer service support application that strongly supports both appropriate sales and sales promotion, to drugstores and other OTC retailers, and have a wealth of data accumulated through these DX tools on healthcare product sales and pre-purchase behavior of consumers.
The Alfresa Group, with its parent company, Alfresa Holdings Corporation, as a pure holding company, is Japan's No. 1 ethical pharmaceutical wholesaler with consolidated sales of more than 2.8 trillion yen, and is engaged in businesses ranging from the development and manufacture of pharmaceutical products to distribution and operation of dispensing pharmacies.
We have formulated the "Alfresa Group Medium- to Long-Term Vision," a medium- to long-term business strategy and financial and capital strategy through fiscal 2032, aiming to create social value in the form of "extension of healthy life expectancy," "contribution to community medicine," and "healthcare innovation" through strengthening and expanding total supply chain services. 3.
Alfresa Healthcare promotes "self-medication" and "self-prevention" to contribute to the realization of a healthy and vibrant society, and provides products and services related to "beauty and health" such as health foods, lifestyle-related products, and beauty care products, mainly over-the-counter drugs, to drugstores, pharmacies, drug stores and other retail outlets. We also provide products and services related to "beauty and health" to drugstores, pharmacies, drugstores, and other retail outlets. In addition, we have developed our own service, "Alfresa Healthcare Solution (AHS)," and are promoting sales floor proposals through exhibitions such as "Life Support Fair" and "Solution Proposal Business Meetings," as well as data-based initiatives such as shelf allocation proposals based on the Consumer Purchase Decision Tree (CDT)*4 . We also provide comprehensive support to resolve issues faced by our customers and business partners by promoting "Life Support Fair," "Solution Proposal Business Meetings," and other exhibitions.
With the conclusion of this agreement, we will work together with Alfresa Healthcare to strongly promote the spread and expansion of the DX tools that we provide. We will also utilize our wealth of data to develop new sales and purchase methods for healthcare products, market forecasts for healthcare products, new product planning, and sales promotion and other support services. Through these activities, we will realize our vision of "making healthcare normal and natural" and contribute to solving healthcare-related issues in Japanese society.
1 CureBell: A website that supports the appropriate selection of over-the-counter drugs and supplements for the purpose of promoting self-medication. In October 2024, a supplement selection function was added, enabling comparison of prices, nutritional ingredients, and GMP/doping certification in a unified format, making it a highly reliable platform used not only by the general public but also by healthcare professionals. It has become a highly reliable platform used not only by the general public but also by medical professionals.
https://curebell.jp
2 D-Counselor neo: An application specialized in supporting customer service for OTC drug sales. It has a function that enables pharmacists and registered sales representatives to select appropriate products based on a thorough interview of symptoms, medical history, and preferences. It also has a function to check customer information and inventory status at each store in real time, and an alert function that contributes to the prevention of drug abuse among young people, thus achieving both sales promotion and appropriate sales.
3 Reference: May 15, 2023 announcement, "Alfresa Group Medium- to Long-term VisionThe Formulation of the "The New York Times."
4 Consumer Purchase Decision Tree (CDT): An analytical tool that visualizes the decision-making process in a hierarchical manner when consumers select products.
Details of Business Alliance
(1) Alfresa Healthcare's use and sale of various data held by the Company
(2) Sales of services provided by Alfresa Healthcare
(3) Collaboration in areas agreed upon by the Company and Alfresa Healthcare
The details of the work will be discussed and a separate contract will be signed in the future.
Alfresa Healthcare Corporation|Company Profile (as of April 28, 2025)
| name of company | Alfresa Healthcare Corporation (Alfresa Healthcare Corporation) |
| Establishment | October 1, 2011 |
| Location | Nihonbashi Hakozaki-Bldg. 6 & 7F, 24-1 Nihonbashi Hakozaki-cho, Chuo-ku, Tokyo |
| representative | Makoto Nishida, President and Representative Director Representative Director Hisashi Katsuki |
| capital stock | 499 million yen |
| Net sales (FY2023 actual) | 262.8 billion yen (FY3/2024) |
| Number of Employees | 402 (as of March 31, 2024) |
| Business | Wholesale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, dairy products for child care, sundries, etc. |
schedule
Date of conclusion of capital and business alliance agreement: March 24, 2025
Willbase, Inc.
| name of company | Willbase, Inc. |
| Establishment | December 2016 |
| Location | 5F H1O Nihonbashi Kobunacho, 8-6 Nihonbashi Kobunacho, Chuo-ku, Tokyo |
| representative | Yuki Tanaka |
| uniform resouce locator | https://www.willbase.co.jp/ |









